Antiinfektives drug-monitoring - Nicht nur nebenwirkungen vermindern! Drug-monitoring am Universitätsklinikum Freiburg

Publikation: Beiträge in ZeitschriftenÜbersichtsarbeitenForschung

Standard

Antiinfektives drug-monitoring - Nicht nur nebenwirkungen vermindern! Drug-monitoring am Universitätsklinikum Freiburg. / Trittler, Rainer; Ehrlich, Markus; Egle, Hannes et al.

in: Krankenhauspharmazie, Jahrgang 25, Nr. 2, 02.2004, S. 53-58.

Publikation: Beiträge in ZeitschriftenÜbersichtsarbeitenForschung

Harvard

APA

Vancouver

Bibtex

@article{54ce49d6c9924c32a9223485301e4234,
title = "Antiinfektives drug-monitoring - Nicht nur nebenwirkungen vermindern! Drug-monitoring am Universit{\"a}tsklinikum Freiburg",
abstract = "The activities in antibiotic drug-monitoring for improvement of antibiotic and/or antimycotic chemotherapies at the University Hospital Freiburg are represented. On the basis of examples such as cystic fibrosis, hand surgery and intensive medicine it is shown how antibiotic therapy can be improved by antiinfective drug monitoring. Furthermore knowledge can be gained, whether the concentration of the active compound is high enough and a rational therapy can be accomplished. This is increasingly interesting in particular in the context of the introduction of the DRGs. Improvements in patient-individual therapy can also reduce costs.",
keywords = "Ceftazidime, Drug monitoring, Fluconazole, Meropenem, Piperacillin, Tazobactam",
author = "Rainer Trittler and Markus Ehrlich and Hannes Egle and Klaus K{\"u}mmerer",
year = "2004",
month = feb,
language = "Deutsch",
volume = "25",
pages = "53--58",
journal = "Krankenhauspharmazie",
issn = "0173-7597",
publisher = "Deutscher Apotheker Verlag Dr. Roland Schmiedel GmbH & Co",
number = "2",

}

RIS

TY - JOUR

T1 - Antiinfektives drug-monitoring - Nicht nur nebenwirkungen vermindern! Drug-monitoring am Universitätsklinikum Freiburg

AU - Trittler, Rainer

AU - Ehrlich, Markus

AU - Egle, Hannes

AU - Kümmerer, Klaus

PY - 2004/2

Y1 - 2004/2

N2 - The activities in antibiotic drug-monitoring for improvement of antibiotic and/or antimycotic chemotherapies at the University Hospital Freiburg are represented. On the basis of examples such as cystic fibrosis, hand surgery and intensive medicine it is shown how antibiotic therapy can be improved by antiinfective drug monitoring. Furthermore knowledge can be gained, whether the concentration of the active compound is high enough and a rational therapy can be accomplished. This is increasingly interesting in particular in the context of the introduction of the DRGs. Improvements in patient-individual therapy can also reduce costs.

AB - The activities in antibiotic drug-monitoring for improvement of antibiotic and/or antimycotic chemotherapies at the University Hospital Freiburg are represented. On the basis of examples such as cystic fibrosis, hand surgery and intensive medicine it is shown how antibiotic therapy can be improved by antiinfective drug monitoring. Furthermore knowledge can be gained, whether the concentration of the active compound is high enough and a rational therapy can be accomplished. This is increasingly interesting in particular in the context of the introduction of the DRGs. Improvements in patient-individual therapy can also reduce costs.

KW - Ceftazidime

KW - Drug monitoring

KW - Fluconazole

KW - Meropenem

KW - Piperacillin

KW - Tazobactam

UR - http://www.scopus.com/inward/record.url?scp=1042265413&partnerID=8YFLogxK

M3 - Übersichtsarbeiten

AN - SCOPUS:1042265413

VL - 25

SP - 53

EP - 58

JO - Krankenhauspharmazie

JF - Krankenhauspharmazie

SN - 0173-7597

IS - 2

ER -